The predictive markers of severity and mortality in hospitalized hemodialysis patients with COVID‐19 during Omicron epidemic

Introduction Predictive markers and prognosis remain unclear in hospitalized hemodialysis (HD) patients with coronavirus disease 2019 (COVID‐19) during the Omicron epidemic. Methods We evaluated characteristics, laboratory parameters, and outcomes in hospitalized HD patients with COVID‐19 (n = 102)...

Full description

Saved in:
Bibliographic Details
Published in:Therapeutic apheresis and dialysis 2023-08, Vol.27 (4), p.701-710
Main Authors: Banshodani, Masataka, Kawanishi, Hideki, Hirai, Takayuki, Kawai, Yusuke, Hashimoto, Shinji, Shintaku, Sadanori, Moriishi, Misaki, Marubayashi, Seiji, Tsuchiya, Shinichiro
Format: Article
Language:English
Subjects:
CCL17
COVID-19 - therapy
COVID‐19
hemodialysis
Humans
Multivariate Analysis
Omicron variant
Renal Dialysis
SARS‐CoV‐2
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c3670-ad9fd7c214e787c0fb5d4a76c2a75af2481e31a6f00a583b3fb455d8b83380a03
cites cdi_FETCH-LOGICAL-c3670-ad9fd7c214e787c0fb5d4a76c2a75af2481e31a6f00a583b3fb455d8b83380a03
container_end_page 710
container_issue 4
container_start_page 701
container_title Therapeutic apheresis and dialysis
container_volume 27
creator Banshodani, Masataka
Kawanishi, Hideki
Hirai, Takayuki
Kawai, Yusuke
Hashimoto, Shinji
Shintaku, Sadanori
Moriishi, Misaki
Marubayashi, Seiji
Tsuchiya, Shinichiro
description Introduction Predictive markers and prognosis remain unclear in hospitalized hemodialysis (HD) patients with coronavirus disease 2019 (COVID‐19) during the Omicron epidemic. Methods We evaluated characteristics, laboratory parameters, and outcomes in hospitalized HD patients with COVID‐19 (n = 102) at two centers between January and April 2022. Results The 30‐day mortality rate was higher in moderate–critical group (n = 43) than mild group (n = 59) (16.3% vs. 1.7%; p = 0.007), and higher in patients with lower CC chemokine ligand 17 (CCL17) levels (
doi_str_mv 10.1111/1744-9987.13970
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2769375840</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2769375840</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3670-ad9fd7c214e787c0fb5d4a76c2a75af2481e31a6f00a583b3fb455d8b83380a03</originalsourceid><addsrcrecordid>eNqFkLtOwzAUhi0EolCY2ZBHlrZ27MTJWJVbpUplKKyWE59QQ27YSasyIB6BZ-RJSGjpipdz0edfRx9CF5QMaftGVHA-iKJQDCmLBDlAJ_vN4b4XUQ-dOvdCiOdxxo5RjwVBRFnAT9DHYgm4sqBNUpsV4FzZV7AOlyl2sAJr6g1WhcZ5aWuVdZMp8LJ0lenGd9B4CXmpjco2zjhcqdpAUTu8NvUST-ZP0-vvzy8aYd1YUzzjeW4SWxYYKqOh7c_QUaoyB-e72kePtzeLyf1gNr-bTsazQcICQQZKR6kWiUc5iFAkJI19zZUIEk8JX6UeDykwqoKUEOWHLGZpzH1fh3HIWEgUYX10tc2tbPnWgKtlblwCWaYKKBsnPRFETPgh79DRFm0Pdc5CKitrWi0bSYnspMtOq-wUy1_p7Y_LXXgT56D3_J_lFvC3wNpksPkvTy7GD9vgH2rRjtc</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2769375840</pqid></control><display><type>article</type><title>The predictive markers of severity and mortality in hospitalized hemodialysis patients with COVID‐19 during Omicron epidemic</title><source>Wiley</source><creator>Banshodani, Masataka ; Kawanishi, Hideki ; Hirai, Takayuki ; Kawai, Yusuke ; Hashimoto, Shinji ; Shintaku, Sadanori ; Moriishi, Misaki ; Marubayashi, Seiji ; Tsuchiya, Shinichiro</creator><creatorcontrib>Banshodani, Masataka ; Kawanishi, Hideki ; Hirai, Takayuki ; Kawai, Yusuke ; Hashimoto, Shinji ; Shintaku, Sadanori ; Moriishi, Misaki ; Marubayashi, Seiji ; Tsuchiya, Shinichiro</creatorcontrib><description>Introduction Predictive markers and prognosis remain unclear in hospitalized hemodialysis (HD) patients with coronavirus disease 2019 (COVID‐19) during the Omicron epidemic. Methods We evaluated characteristics, laboratory parameters, and outcomes in hospitalized HD patients with COVID‐19 (n = 102) at two centers between January and April 2022. Results The 30‐day mortality rate was higher in moderate–critical group (n = 43) than mild group (n = 59) (16.3% vs. 1.7%; p = 0.007), and higher in patients with lower CC chemokine ligand 17 (CCL17) levels (&lt;95.0 pg/mL) compared with normal CCL17 levels (19.0% versus 4.9%; p = 0.03). In multivariate analyses, a low CCL17 level (p = 0.003) was associated with moderate–critical conditions, and moderate–critical conditions (p = 0.04) were associated with 30‐day mortality, whereas CCL17 was not associated with 30‐day mortality. Conclusions COVID‐19 remains a fatal complication, and CCL17 was a predictive marker of severity in hospitalized HD patients during the Omicron epidemic.</description><identifier>ISSN: 1744-9979</identifier><identifier>EISSN: 1744-9987</identifier><identifier>DOI: 10.1111/1744-9987.13970</identifier><identifier>PMID: 36691364</identifier><language>eng</language><publisher>Kyoto, Japan: John Wiley &amp; Sons Australia, Ltd</publisher><subject>CCL17 ; COVID-19 - therapy ; COVID‐19 ; hemodialysis ; Humans ; Multivariate Analysis ; Omicron variant ; Renal Dialysis ; SARS‐CoV‐2</subject><ispartof>Therapeutic apheresis and dialysis, 2023-08, Vol.27 (4), p.701-710</ispartof><rights>2023 International Society for Apheresis and Japanese Society for Apheresis.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3670-ad9fd7c214e787c0fb5d4a76c2a75af2481e31a6f00a583b3fb455d8b83380a03</citedby><cites>FETCH-LOGICAL-c3670-ad9fd7c214e787c0fb5d4a76c2a75af2481e31a6f00a583b3fb455d8b83380a03</cites><orcidid>0000-0001-9653-2279 ; 0000-0001-5200-460X</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/36691364$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Banshodani, Masataka</creatorcontrib><creatorcontrib>Kawanishi, Hideki</creatorcontrib><creatorcontrib>Hirai, Takayuki</creatorcontrib><creatorcontrib>Kawai, Yusuke</creatorcontrib><creatorcontrib>Hashimoto, Shinji</creatorcontrib><creatorcontrib>Shintaku, Sadanori</creatorcontrib><creatorcontrib>Moriishi, Misaki</creatorcontrib><creatorcontrib>Marubayashi, Seiji</creatorcontrib><creatorcontrib>Tsuchiya, Shinichiro</creatorcontrib><title>The predictive markers of severity and mortality in hospitalized hemodialysis patients with COVID‐19 during Omicron epidemic</title><title>Therapeutic apheresis and dialysis</title><addtitle>Ther Apher Dial</addtitle><description>Introduction Predictive markers and prognosis remain unclear in hospitalized hemodialysis (HD) patients with coronavirus disease 2019 (COVID‐19) during the Omicron epidemic. Methods We evaluated characteristics, laboratory parameters, and outcomes in hospitalized HD patients with COVID‐19 (n = 102) at two centers between January and April 2022. Results The 30‐day mortality rate was higher in moderate–critical group (n = 43) than mild group (n = 59) (16.3% vs. 1.7%; p = 0.007), and higher in patients with lower CC chemokine ligand 17 (CCL17) levels (&lt;95.0 pg/mL) compared with normal CCL17 levels (19.0% versus 4.9%; p = 0.03). In multivariate analyses, a low CCL17 level (p = 0.003) was associated with moderate–critical conditions, and moderate–critical conditions (p = 0.04) were associated with 30‐day mortality, whereas CCL17 was not associated with 30‐day mortality. Conclusions COVID‐19 remains a fatal complication, and CCL17 was a predictive marker of severity in hospitalized HD patients during the Omicron epidemic.</description><subject>CCL17</subject><subject>COVID-19 - therapy</subject><subject>COVID‐19</subject><subject>hemodialysis</subject><subject>Humans</subject><subject>Multivariate Analysis</subject><subject>Omicron variant</subject><subject>Renal Dialysis</subject><subject>SARS‐CoV‐2</subject><issn>1744-9979</issn><issn>1744-9987</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><recordid>eNqFkLtOwzAUhi0EolCY2ZBHlrZ27MTJWJVbpUplKKyWE59QQ27YSasyIB6BZ-RJSGjpipdz0edfRx9CF5QMaftGVHA-iKJQDCmLBDlAJ_vN4b4XUQ-dOvdCiOdxxo5RjwVBRFnAT9DHYgm4sqBNUpsV4FzZV7AOlyl2sAJr6g1WhcZ5aWuVdZMp8LJ0lenGd9B4CXmpjco2zjhcqdpAUTu8NvUST-ZP0-vvzy8aYd1YUzzjeW4SWxYYKqOh7c_QUaoyB-e72kePtzeLyf1gNr-bTsazQcICQQZKR6kWiUc5iFAkJI19zZUIEk8JX6UeDykwqoKUEOWHLGZpzH1fh3HIWEgUYX10tc2tbPnWgKtlblwCWaYKKBsnPRFETPgh79DRFm0Pdc5CKitrWi0bSYnspMtOq-wUy1_p7Y_LXXgT56D3_J_lFvC3wNpksPkvTy7GD9vgH2rRjtc</recordid><startdate>202308</startdate><enddate>202308</enddate><creator>Banshodani, Masataka</creator><creator>Kawanishi, Hideki</creator><creator>Hirai, Takayuki</creator><creator>Kawai, Yusuke</creator><creator>Hashimoto, Shinji</creator><creator>Shintaku, Sadanori</creator><creator>Moriishi, Misaki</creator><creator>Marubayashi, Seiji</creator><creator>Tsuchiya, Shinichiro</creator><general>John Wiley &amp; Sons Australia, Ltd</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0001-9653-2279</orcidid><orcidid>https://orcid.org/0000-0001-5200-460X</orcidid></search><sort><creationdate>202308</creationdate><title>The predictive markers of severity and mortality in hospitalized hemodialysis patients with COVID‐19 during Omicron epidemic</title><author>Banshodani, Masataka ; Kawanishi, Hideki ; Hirai, Takayuki ; Kawai, Yusuke ; Hashimoto, Shinji ; Shintaku, Sadanori ; Moriishi, Misaki ; Marubayashi, Seiji ; Tsuchiya, Shinichiro</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3670-ad9fd7c214e787c0fb5d4a76c2a75af2481e31a6f00a583b3fb455d8b83380a03</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><topic>CCL17</topic><topic>COVID-19 - therapy</topic><topic>COVID‐19</topic><topic>hemodialysis</topic><topic>Humans</topic><topic>Multivariate Analysis</topic><topic>Omicron variant</topic><topic>Renal Dialysis</topic><topic>SARS‐CoV‐2</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Banshodani, Masataka</creatorcontrib><creatorcontrib>Kawanishi, Hideki</creatorcontrib><creatorcontrib>Hirai, Takayuki</creatorcontrib><creatorcontrib>Kawai, Yusuke</creatorcontrib><creatorcontrib>Hashimoto, Shinji</creatorcontrib><creatorcontrib>Shintaku, Sadanori</creatorcontrib><creatorcontrib>Moriishi, Misaki</creatorcontrib><creatorcontrib>Marubayashi, Seiji</creatorcontrib><creatorcontrib>Tsuchiya, Shinichiro</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Therapeutic apheresis and dialysis</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Banshodani, Masataka</au><au>Kawanishi, Hideki</au><au>Hirai, Takayuki</au><au>Kawai, Yusuke</au><au>Hashimoto, Shinji</au><au>Shintaku, Sadanori</au><au>Moriishi, Misaki</au><au>Marubayashi, Seiji</au><au>Tsuchiya, Shinichiro</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The predictive markers of severity and mortality in hospitalized hemodialysis patients with COVID‐19 during Omicron epidemic</atitle><jtitle>Therapeutic apheresis and dialysis</jtitle><addtitle>Ther Apher Dial</addtitle><date>2023-08</date><risdate>2023</risdate><volume>27</volume><issue>4</issue><spage>701</spage><epage>710</epage><pages>701-710</pages><issn>1744-9979</issn><eissn>1744-9987</eissn><abstract>Introduction Predictive markers and prognosis remain unclear in hospitalized hemodialysis (HD) patients with coronavirus disease 2019 (COVID‐19) during the Omicron epidemic. Methods We evaluated characteristics, laboratory parameters, and outcomes in hospitalized HD patients with COVID‐19 (n = 102) at two centers between January and April 2022. Results The 30‐day mortality rate was higher in moderate–critical group (n = 43) than mild group (n = 59) (16.3% vs. 1.7%; p = 0.007), and higher in patients with lower CC chemokine ligand 17 (CCL17) levels (&lt;95.0 pg/mL) compared with normal CCL17 levels (19.0% versus 4.9%; p = 0.03). In multivariate analyses, a low CCL17 level (p = 0.003) was associated with moderate–critical conditions, and moderate–critical conditions (p = 0.04) were associated with 30‐day mortality, whereas CCL17 was not associated with 30‐day mortality. Conclusions COVID‐19 remains a fatal complication, and CCL17 was a predictive marker of severity in hospitalized HD patients during the Omicron epidemic.</abstract><cop>Kyoto, Japan</cop><pub>John Wiley &amp; Sons Australia, Ltd</pub><pmid>36691364</pmid><doi>10.1111/1744-9987.13970</doi><tpages>10</tpages><orcidid>https://orcid.org/0000-0001-9653-2279</orcidid><orcidid>https://orcid.org/0000-0001-5200-460X</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 1744-9979
ispartof Therapeutic apheresis and dialysis, 2023-08, Vol.27 (4), p.701-710
issn 1744-9979
1744-9987
language eng
recordid cdi_proquest_miscellaneous_2769375840
source Wiley
subjects CCL17
COVID-19 - therapy
COVID‐19
hemodialysis
Humans
Multivariate Analysis
Omicron variant
Renal Dialysis
SARS‐CoV‐2
title The predictive markers of severity and mortality in hospitalized hemodialysis patients with COVID‐19 during Omicron epidemic
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-29T09%3A58%3A28IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20predictive%20markers%20of%20severity%20and%20mortality%20in%20hospitalized%20hemodialysis%20patients%20with%20COVID%E2%80%9019%20during%20Omicron%20epidemic&rft.jtitle=Therapeutic%20apheresis%20and%20dialysis&rft.au=Banshodani,%20Masataka&rft.date=2023-08&rft.volume=27&rft.issue=4&rft.spage=701&rft.epage=710&rft.pages=701-710&rft.issn=1744-9979&rft.eissn=1744-9987&rft_id=info:doi/10.1111/1744-9987.13970&rft_dat=%3Cproquest_cross%3E2769375840%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c3670-ad9fd7c214e787c0fb5d4a76c2a75af2481e31a6f00a583b3fb455d8b83380a03%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2769375840&rft_id=info:pmid/36691364&rfr_iscdi=true